nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ORM1—Imatinib—hematologic cancer	0.0769	1	CbGbCtD
Penbutolol—Headache—Imatinib—hematologic cancer	0.000594	0.000748	CcSEcCtD
Penbutolol—Asthenia—Lenalidomide—hematologic cancer	0.000593	0.000747	CcSEcCtD
Penbutolol—Hyperhidrosis—Mitoxantrone—hematologic cancer	0.000592	0.000746	CcSEcCtD
Penbutolol—Hyperhidrosis—Irinotecan—hematologic cancer	0.000592	0.000746	CcSEcCtD
Penbutolol—Fatigue—Thalidomide—hematologic cancer	0.000591	0.000745	CcSEcCtD
Penbutolol—Erectile dysfunction—Prednisone—hematologic cancer	0.000591	0.000745	CcSEcCtD
Penbutolol—Dizziness—Vinblastine—hematologic cancer	0.000591	0.000744	CcSEcCtD
Penbutolol—Insomnia—Alitretinoin—hematologic cancer	0.00059	0.000743	CcSEcCtD
Penbutolol—Mood swings—Methotrexate—hematologic cancer	0.000588	0.000741	CcSEcCtD
Penbutolol—Dyspnoea—Carmustine—hematologic cancer	0.000587	0.00074	CcSEcCtD
Penbutolol—Body temperature increased—Vinorelbine—hematologic cancer	0.000587	0.000739	CcSEcCtD
Penbutolol—Pain—Thalidomide—hematologic cancer	0.000586	0.000739	CcSEcCtD
Penbutolol—Asthenia—Hydroxyurea—hematologic cancer	0.000584	0.000736	CcSEcCtD
Penbutolol—Headache—Cladribine—hematologic cancer	0.000583	0.000735	CcSEcCtD
Penbutolol—Dyspnoea—Alitretinoin—hematologic cancer	0.000582	0.000733	CcSEcCtD
Penbutolol—Diarrhoea—Melphalan—hematologic cancer	0.000581	0.000732	CcSEcCtD
Penbutolol—Nausea—Chlorambucil—hematologic cancer	0.000579	0.000729	CcSEcCtD
Penbutolol—Hyperhidrosis—Gemcitabine—hematologic cancer	0.000577	0.000726	CcSEcCtD
Penbutolol—Dyspnoea—Ifosfamide—hematologic cancer	0.000575	0.000724	CcSEcCtD
Penbutolol—Dyspepsia—Alitretinoin—hematologic cancer	0.000574	0.000723	CcSEcCtD
Penbutolol—Affect lability—Epirubicin—hematologic cancer	0.000572	0.00072	CcSEcCtD
Penbutolol—Depression—Prednisone—hematologic cancer	0.000571	0.000719	CcSEcCtD
Penbutolol—Insomnia—Vincristine—hematologic cancer	0.000569	0.000716	CcSEcCtD
Penbutolol—Nausea—Nilotinib—hematologic cancer	0.000566	0.000713	CcSEcCtD
Penbutolol—Diarrhoea—Lenalidomide—hematologic cancer	0.000565	0.000712	CcSEcCtD
Penbutolol—Pain—Carmustine—hematologic cancer	0.000563	0.000709	CcSEcCtD
Penbutolol—Nausea—Imatinib—hematologic cancer	0.000563	0.000709	CcSEcCtD
Penbutolol—Fatigue—Alitretinoin—hematologic cancer	0.000562	0.000709	CcSEcCtD
Penbutolol—Body temperature increased—Thiotepa—hematologic cancer	0.00056	0.000706	CcSEcCtD
Penbutolol—Headache—Vinblastine—hematologic cancer	0.00056	0.000705	CcSEcCtD
Penbutolol—Pain—Alitretinoin—hematologic cancer	0.000558	0.000703	CcSEcCtD
Penbutolol—Diarrhoea—Hydroxyurea—hematologic cancer	0.000557	0.000702	CcSEcCtD
Penbutolol—Fatigue—Ifosfamide—hematologic cancer	0.000556	0.0007	CcSEcCtD
Penbutolol—Insomnia—Irinotecan—hematologic cancer	0.000554	0.000698	CcSEcCtD
Penbutolol—Nausea—Cladribine—hematologic cancer	0.000553	0.000697	CcSEcCtD
Penbutolol—Pain—Ifosfamide—hematologic cancer	0.000551	0.000695	CcSEcCtD
Penbutolol—Mood swings—Epirubicin—hematologic cancer	0.00055	0.000693	CcSEcCtD
Penbutolol—Dizziness—Lenalidomide—hematologic cancer	0.000546	0.000688	CcSEcCtD
Penbutolol—Dyspnoea—Mitoxantrone—hematologic cancer	0.000546	0.000688	CcSEcCtD
Penbutolol—Dyspnoea—Irinotecan—hematologic cancer	0.000546	0.000688	CcSEcCtD
Penbutolol—Asthenia—Bortezomib—hematologic cancer	0.000545	0.000687	CcSEcCtD
Penbutolol—Cough—Etoposide—hematologic cancer	0.000544	0.000686	CcSEcCtD
Penbutolol—Body temperature increased—Thalidomide—hematologic cancer	0.000542	0.000683	CcSEcCtD
Penbutolol—Fatigue—Vincristine—hematologic cancer	0.000542	0.000683	CcSEcCtD
Penbutolol—Asthenia—Bleomycin—hematologic cancer	0.000541	0.000682	CcSEcCtD
Penbutolol—Insomnia—Gemcitabine—hematologic cancer	0.000539	0.000679	CcSEcCtD
Penbutolol—Dyspepsia—Irinotecan—hematologic cancer	0.000539	0.000679	CcSEcCtD
Penbutolol—Dyspepsia—Mitoxantrone—hematologic cancer	0.000539	0.000679	CcSEcCtD
Penbutolol—Dizziness—Hydroxyurea—hematologic cancer	0.000539	0.000679	CcSEcCtD
Penbutolol—Pain—Vincristine—hematologic cancer	0.000538	0.000677	CcSEcCtD
Penbutolol—Hyperhidrosis—Cisplatin—hematologic cancer	0.000537	0.000677	CcSEcCtD
Penbutolol—Asthenia—Vinorelbine—hematologic cancer	0.000533	0.000671	CcSEcCtD
Penbutolol—Dyspnoea—Gemcitabine—hematologic cancer	0.000532	0.00067	CcSEcCtD
Penbutolol—Nausea—Vinblastine—hematologic cancer	0.000531	0.000668	CcSEcCtD
Penbutolol—Affect lability—Doxorubicin—hematologic cancer	0.000529	0.000666	CcSEcCtD
Penbutolol—Fatigue—Mitoxantrone—hematologic cancer	0.000528	0.000665	CcSEcCtD
Penbutolol—Fatigue—Irinotecan—hematologic cancer	0.000528	0.000665	CcSEcCtD
Penbutolol—Pain—Irinotecan—hematologic cancer	0.000524	0.00066	CcSEcCtD
Penbutolol—Pain—Mitoxantrone—hematologic cancer	0.000524	0.00066	CcSEcCtD
Penbutolol—Bradycardia—Prednisone—hematologic cancer	0.000523	0.000659	CcSEcCtD
Penbutolol—Alopecia—Betamethasone—hematologic cancer	0.000521	0.000657	CcSEcCtD
Penbutolol—Alopecia—Dexamethasone—hematologic cancer	0.000521	0.000657	CcSEcCtD
Penbutolol—Body temperature increased—Carmustine—hematologic cancer	0.000521	0.000656	CcSEcCtD
Penbutolol—Diarrhoea—Bortezomib—hematologic cancer	0.00052	0.000655	CcSEcCtD
Penbutolol—Headache—Lenalidomide—hematologic cancer	0.000518	0.000652	CcSEcCtD
Penbutolol—Body temperature increased—Alitretinoin—hematologic cancer	0.000516	0.00065	CcSEcCtD
Penbutolol—Fatigue—Gemcitabine—hematologic cancer	0.000514	0.000648	CcSEcCtD
Penbutolol—Headache—Hydroxyurea—hematologic cancer	0.00051	0.000643	CcSEcCtD
Penbutolol—Pain—Gemcitabine—hematologic cancer	0.00051	0.000642	CcSEcCtD
Penbutolol—Body temperature increased—Ifosfamide—hematologic cancer	0.00051	0.000642	CcSEcCtD
Penbutolol—Mood swings—Doxorubicin—hematologic cancer	0.000509	0.000641	CcSEcCtD
Penbutolol—Asthenia—Thiotepa—hematologic cancer	0.000509	0.000641	CcSEcCtD
Penbutolol—Diarrhoea—Vinorelbine—hematologic cancer	0.000508	0.00064	CcSEcCtD
Penbutolol—Nausea—Melphalan—hematologic cancer	0.000505	0.000636	CcSEcCtD
Penbutolol—Dizziness—Bortezomib—hematologic cancer	0.000503	0.000633	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Methotrexate—hematologic cancer	0.000499	0.000628	CcSEcCtD
Penbutolol—Body temperature increased—Vincristine—hematologic cancer	0.000497	0.000626	CcSEcCtD
Penbutolol—Dyspnoea—Cisplatin—hematologic cancer	0.000496	0.000624	CcSEcCtD
Penbutolol—Erectile dysfunction—Methotrexate—hematologic cancer	0.000494	0.000622	CcSEcCtD
Penbutolol—Cough—Triamcinolone—hematologic cancer	0.000494	0.000622	CcSEcCtD
Penbutolol—Hyperhidrosis—Etoposide—hematologic cancer	0.000492	0.00062	CcSEcCtD
Penbutolol—Asthenia—Thalidomide—hematologic cancer	0.000492	0.00062	CcSEcCtD
Penbutolol—Dizziness—Vinorelbine—hematologic cancer	0.000491	0.000618	CcSEcCtD
Penbutolol—Nausea—Lenalidomide—hematologic cancer	0.000491	0.000618	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisolone—hematologic cancer	0.000486	0.000612	CcSEcCtD
Penbutolol—Diarrhoea—Thiotepa—hematologic cancer	0.000485	0.000611	CcSEcCtD
Penbutolol—Body temperature increased—Mitoxantrone—hematologic cancer	0.000484	0.00061	CcSEcCtD
Penbutolol—Body temperature increased—Irinotecan—hematologic cancer	0.000484	0.00061	CcSEcCtD
Penbutolol—Nausea—Hydroxyurea—hematologic cancer	0.000484	0.00061	CcSEcCtD
Penbutolol—Depression—Methotrexate—hematologic cancer	0.000477	0.000601	CcSEcCtD
Penbutolol—Headache—Bortezomib—hematologic cancer	0.000476	0.0006	CcSEcCtD
Penbutolol—Pain—Cisplatin—hematologic cancer	0.000475	0.000599	CcSEcCtD
Penbutolol—Asthenia—Carmustine—hematologic cancer	0.000472	0.000595	CcSEcCtD
Penbutolol—Body temperature increased—Gemcitabine—hematologic cancer	0.000471	0.000594	CcSEcCtD
Penbutolol—Diarrhoea—Thalidomide—hematologic cancer	0.000469	0.000591	CcSEcCtD
Penbutolol—Dizziness—Thiotepa—hematologic cancer	0.000469	0.000591	CcSEcCtD
Penbutolol—Asthenia—Alitretinoin—hematologic cancer	0.000468	0.00059	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.000467	0.000588	CcSEcCtD
Penbutolol—Headache—Vinorelbine—hematologic cancer	0.000465	0.000586	CcSEcCtD
Penbutolol—Asthenia—Ifosfamide—hematologic cancer	0.000463	0.000583	CcSEcCtD
Penbutolol—Sweating—Methotrexate—hematologic cancer	0.000458	0.000578	CcSEcCtD
Penbutolol—Insomnia—Prednisolone—hematologic cancer	0.000454	0.000572	CcSEcCtD
Penbutolol—Dyspnoea—Etoposide—hematologic cancer	0.000454	0.000572	CcSEcCtD
Penbutolol—Alopecia—Prednisone—hematologic cancer	0.000454	0.000572	CcSEcCtD
Penbutolol—Dizziness—Thalidomide—hematologic cancer	0.000453	0.000571	CcSEcCtD
Penbutolol—Nausea—Bortezomib—hematologic cancer	0.000452	0.000569	CcSEcCtD
Penbutolol—Asthenia—Vincristine—hematologic cancer	0.000451	0.000568	CcSEcCtD
Penbutolol—Diarrhoea—Carmustine—hematologic cancer	0.000451	0.000568	CcSEcCtD
Penbutolol—Nausea—Bleomycin—hematologic cancer	0.000448	0.000565	CcSEcCtD
Penbutolol—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000447	0.000562	CcSEcCtD
Penbutolol—Diarrhoea—Alitretinoin—hematologic cancer	0.000446	0.000562	CcSEcCtD
Penbutolol—Agranulocytosis—Methotrexate—hematologic cancer	0.000446	0.000562	CcSEcCtD
Penbutolol—Headache—Thiotepa—hematologic cancer	0.000444	0.000559	CcSEcCtD
Penbutolol—Diarrhoea—Ifosfamide—hematologic cancer	0.000441	0.000556	CcSEcCtD
Penbutolol—Nausea—Vinorelbine—hematologic cancer	0.000441	0.000555	CcSEcCtD
Penbutolol—Body temperature increased—Cisplatin—hematologic cancer	0.000439	0.000554	CcSEcCtD
Penbutolol—Asthenia—Irinotecan—hematologic cancer	0.000439	0.000553	CcSEcCtD
Penbutolol—Asthenia—Mitoxantrone—hematologic cancer	0.000439	0.000553	CcSEcCtD
Penbutolol—Fatigue—Etoposide—hematologic cancer	0.000439	0.000553	CcSEcCtD
Penbutolol—Dizziness—Carmustine—hematologic cancer	0.000435	0.000549	CcSEcCtD
Penbutolol—Pain—Etoposide—hematologic cancer	0.000435	0.000549	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.000432	0.000544	CcSEcCtD
Penbutolol—Dizziness—Alitretinoin—hematologic cancer	0.000431	0.000543	CcSEcCtD
Penbutolol—Diarrhoea—Vincristine—hematologic cancer	0.00043	0.000542	CcSEcCtD
Penbutolol—Headache—Thalidomide—hematologic cancer	0.00043	0.000541	CcSEcCtD
Penbutolol—Pain—Prednisolone—hematologic cancer	0.00043	0.000541	CcSEcCtD
Penbutolol—Sweating—Epirubicin—hematologic cancer	0.000429	0.000541	CcSEcCtD
Penbutolol—Asthenia—Gemcitabine—hematologic cancer	0.000428	0.000539	CcSEcCtD
Penbutolol—Dizziness—Ifosfamide—hematologic cancer	0.000426	0.000537	CcSEcCtD
Penbutolol—Nausea—Thiotepa—hematologic cancer	0.000421	0.00053	CcSEcCtD
Penbutolol—Diarrhoea—Irinotecan—hematologic cancer	0.000419	0.000528	CcSEcCtD
Penbutolol—Diarrhoea—Mitoxantrone—hematologic cancer	0.000419	0.000528	CcSEcCtD
Penbutolol—Insomnia—Triamcinolone—hematologic cancer	0.000418	0.000526	CcSEcCtD
Penbutolol—Agranulocytosis—Epirubicin—hematologic cancer	0.000418	0.000526	CcSEcCtD
Penbutolol—Dizziness—Vincristine—hematologic cancer	0.000416	0.000524	CcSEcCtD
Penbutolol—Headache—Carmustine—hematologic cancer	0.000413	0.00052	CcSEcCtD
Penbutolol—Dyspnoea—Triamcinolone—hematologic cancer	0.000412	0.000519	CcSEcCtD
Penbutolol—Bradycardia—Epirubicin—hematologic cancer	0.000409	0.000515	CcSEcCtD
Penbutolol—Headache—Alitretinoin—hematologic cancer	0.000409	0.000515	CcSEcCtD
Penbutolol—Diarrhoea—Gemcitabine—hematologic cancer	0.000408	0.000514	CcSEcCtD
Penbutolol—Nausea—Thalidomide—hematologic cancer	0.000407	0.000513	CcSEcCtD
Penbutolol—Dyspepsia—Triamcinolone—hematologic cancer	0.000407	0.000512	CcSEcCtD
Penbutolol—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000405	0.00051	CcSEcCtD
Penbutolol—Hyperhidrosis—Betamethasone—hematologic cancer	0.000405	0.00051	CcSEcCtD
Penbutolol—Dizziness—Irinotecan—hematologic cancer	0.000405	0.00051	CcSEcCtD
Penbutolol—Body temperature increased—Etoposide—hematologic cancer	0.000403	0.000507	CcSEcCtD
Penbutolol—Asthenia—Cisplatin—hematologic cancer	0.000399	0.000502	CcSEcCtD
Penbutolol—Fatigue—Triamcinolone—hematologic cancer	0.000398	0.000502	CcSEcCtD
Penbutolol—Sweating—Doxorubicin—hematologic cancer	0.000397	0.0005	CcSEcCtD
Penbutolol—Pain—Triamcinolone—hematologic cancer	0.000395	0.000498	CcSEcCtD
Penbutolol—Headache—Vincristine—hematologic cancer	0.000394	0.000496	CcSEcCtD
Penbutolol—Nausea—Carmustine—hematologic cancer	0.000391	0.000493	CcSEcCtD
Penbutolol—Nausea—Alitretinoin—hematologic cancer	0.000387	0.000488	CcSEcCtD
Penbutolol—Agranulocytosis—Doxorubicin—hematologic cancer	0.000386	0.000487	CcSEcCtD
Penbutolol—Headache—Mitoxantrone—hematologic cancer	0.000384	0.000483	CcSEcCtD
Penbutolol—Headache—Irinotecan—hematologic cancer	0.000384	0.000483	CcSEcCtD
Penbutolol—Nausea—Ifosfamide—hematologic cancer	0.000383	0.000482	CcSEcCtD
Penbutolol—Diarrhoea—Cisplatin—hematologic cancer	0.00038	0.000479	CcSEcCtD
Penbutolol—Alopecia—Methotrexate—hematologic cancer	0.000379	0.000478	CcSEcCtD
Penbutolol—Insomnia—Betamethasone—hematologic cancer	0.000379	0.000478	CcSEcCtD
Penbutolol—Insomnia—Dexamethasone—hematologic cancer	0.000379	0.000478	CcSEcCtD
Penbutolol—Bradycardia—Doxorubicin—hematologic cancer	0.000378	0.000477	CcSEcCtD
Penbutolol—Headache—Gemcitabine—hematologic cancer	0.000374	0.000471	CcSEcCtD
Penbutolol—Nausea—Vincristine—hematologic cancer	0.000373	0.00047	CcSEcCtD
Penbutolol—Dyspepsia—Dexamethasone—hematologic cancer	0.000369	0.000465	CcSEcCtD
Penbutolol—Dyspepsia—Betamethasone—hematologic cancer	0.000369	0.000465	CcSEcCtD
Penbutolol—Asthenia—Etoposide—hematologic cancer	0.000365	0.00046	CcSEcCtD
Penbutolol—Body temperature increased—Triamcinolone—hematologic cancer	0.000365	0.00046	CcSEcCtD
Penbutolol—Nausea—Irinotecan—hematologic cancer	0.000364	0.000458	CcSEcCtD
Penbutolol—Nausea—Mitoxantrone—hematologic cancer	0.000364	0.000458	CcSEcCtD
Penbutolol—Fatigue—Betamethasone—hematologic cancer	0.000361	0.000455	CcSEcCtD
Penbutolol—Fatigue—Dexamethasone—hematologic cancer	0.000361	0.000455	CcSEcCtD
Penbutolol—Pain—Dexamethasone—hematologic cancer	0.000358	0.000451	CcSEcCtD
Penbutolol—Pain—Betamethasone—hematologic cancer	0.000358	0.000451	CcSEcCtD
Penbutolol—Alopecia—Epirubicin—hematologic cancer	0.000355	0.000447	CcSEcCtD
Penbutolol—Nausea—Gemcitabine—hematologic cancer	0.000354	0.000446	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisone—hematologic cancer	0.000353	0.000444	CcSEcCtD
Penbutolol—Diarrhoea—Etoposide—hematologic cancer	0.000348	0.000439	CcSEcCtD
Penbutolol—Dizziness—Etoposide—hematologic cancer	0.000337	0.000424	CcSEcCtD
Penbutolol—Dizziness—Prednisolone—hematologic cancer	0.000332	0.000418	CcSEcCtD
Penbutolol—Asthenia—Triamcinolone—hematologic cancer	0.000331	0.000417	CcSEcCtD
Penbutolol—Body temperature increased—Betamethasone—hematologic cancer	0.000331	0.000417	CcSEcCtD
Penbutolol—Body temperature increased—Dexamethasone—hematologic cancer	0.000331	0.000417	CcSEcCtD
Penbutolol—Nausea—Cisplatin—hematologic cancer	0.00033	0.000416	CcSEcCtD
Penbutolol—Insomnia—Prednisone—hematologic cancer	0.00033	0.000416	CcSEcCtD
Penbutolol—Alopecia—Doxorubicin—hematologic cancer	0.000329	0.000414	CcSEcCtD
Penbutolol—Cough—Methotrexate—hematologic cancer	0.000326	0.000411	CcSEcCtD
Penbutolol—Dyspepsia—Prednisone—hematologic cancer	0.000321	0.000405	CcSEcCtD
Penbutolol—Headache—Etoposide—hematologic cancer	0.000319	0.000402	CcSEcCtD
Penbutolol—Fatigue—Prednisone—hematologic cancer	0.000315	0.000396	CcSEcCtD
Penbutolol—Headache—Prednisolone—hematologic cancer	0.000315	0.000396	CcSEcCtD
Penbutolol—Dizziness—Triamcinolone—hematologic cancer	0.000305	0.000385	CcSEcCtD
Penbutolol—Cough—Epirubicin—hematologic cancer	0.000305	0.000384	CcSEcCtD
Penbutolol—Nausea—Etoposide—hematologic cancer	0.000302	0.000381	CcSEcCtD
Penbutolol—Asthenia—Betamethasone—hematologic cancer	0.000301	0.000379	CcSEcCtD
Penbutolol—Asthenia—Dexamethasone—hematologic cancer	0.000301	0.000379	CcSEcCtD
Penbutolol—Nausea—Prednisolone—hematologic cancer	0.000298	0.000376	CcSEcCtD
Penbutolol—Hyperhidrosis—Methotrexate—hematologic cancer	0.000295	0.000371	CcSEcCtD
Penbutolol—Headache—Triamcinolone—hematologic cancer	0.000289	0.000365	CcSEcCtD
Penbutolol—Body temperature increased—Prednisone—hematologic cancer	0.000289	0.000363	CcSEcCtD
Penbutolol—Diarrhoea—Betamethasone—hematologic cancer	0.000287	0.000361	CcSEcCtD
Penbutolol—Diarrhoea—Dexamethasone—hematologic cancer	0.000287	0.000361	CcSEcCtD
Penbutolol—Cough—Doxorubicin—hematologic cancer	0.000282	0.000356	CcSEcCtD
Penbutolol—Dizziness—Dexamethasone—hematologic cancer	0.000277	0.000349	CcSEcCtD
Penbutolol—Dizziness—Betamethasone—hematologic cancer	0.000277	0.000349	CcSEcCtD
Penbutolol—Hyperhidrosis—Epirubicin—hematologic cancer	0.000276	0.000348	CcSEcCtD
Penbutolol—Insomnia—Methotrexate—hematologic cancer	0.000276	0.000348	CcSEcCtD
Penbutolol—Nausea—Triamcinolone—hematologic cancer	0.000274	0.000346	CcSEcCtD
Penbutolol—Dyspnoea—Methotrexate—hematologic cancer	0.000272	0.000343	CcSEcCtD
Penbutolol—Dyspepsia—Methotrexate—hematologic cancer	0.000268	0.000338	CcSEcCtD
Penbutolol—Fatigue—Methotrexate—hematologic cancer	0.000263	0.000331	CcSEcCtD
Penbutolol—Headache—Betamethasone—hematologic cancer	0.000263	0.000331	CcSEcCtD
Penbutolol—Headache—Dexamethasone—hematologic cancer	0.000263	0.000331	CcSEcCtD
Penbutolol—Asthenia—Prednisone—hematologic cancer	0.000262	0.00033	CcSEcCtD
Penbutolol—Pain—Methotrexate—hematologic cancer	0.000261	0.000329	CcSEcCtD
Penbutolol—Insomnia—Epirubicin—hematologic cancer	0.000258	0.000325	CcSEcCtD
Penbutolol—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000255	0.000322	CcSEcCtD
Penbutolol—Dyspnoea—Epirubicin—hematologic cancer	0.000254	0.000321	CcSEcCtD
Penbutolol—Dyspepsia—Epirubicin—hematologic cancer	0.000251	0.000317	CcSEcCtD
Penbutolol—Diarrhoea—Prednisone—hematologic cancer	0.00025	0.000315	CcSEcCtD
Penbutolol—Nausea—Dexamethasone—hematologic cancer	0.000249	0.000314	CcSEcCtD
Penbutolol—Nausea—Betamethasone—hematologic cancer	0.000249	0.000314	CcSEcCtD
Penbutolol—Fatigue—Epirubicin—hematologic cancer	0.000246	0.00031	CcSEcCtD
Penbutolol—Pain—Epirubicin—hematologic cancer	0.000244	0.000308	CcSEcCtD
Penbutolol—Dizziness—Prednisone—hematologic cancer	0.000241	0.000304	CcSEcCtD
Penbutolol—Body temperature increased—Methotrexate—hematologic cancer	0.000241	0.000304	CcSEcCtD
Penbutolol—Insomnia—Doxorubicin—hematologic cancer	0.000239	0.000301	CcSEcCtD
Penbutolol—Dyspnoea—Doxorubicin—hematologic cancer	0.000235	0.000297	CcSEcCtD
Penbutolol—Dyspepsia—Doxorubicin—hematologic cancer	0.000232	0.000293	CcSEcCtD
Penbutolol—Headache—Prednisone—hematologic cancer	0.000229	0.000288	CcSEcCtD
Penbutolol—Fatigue—Doxorubicin—hematologic cancer	0.000228	0.000287	CcSEcCtD
Penbutolol—Pain—Doxorubicin—hematologic cancer	0.000226	0.000285	CcSEcCtD
Penbutolol—Body temperature increased—Epirubicin—hematologic cancer	0.000226	0.000284	CcSEcCtD
Penbutolol—Asthenia—Methotrexate—hematologic cancer	0.000219	0.000276	CcSEcCtD
Penbutolol—Nausea—Prednisone—hematologic cancer	0.000217	0.000273	CcSEcCtD
Penbutolol—Body temperature increased—Doxorubicin—hematologic cancer	0.000209	0.000263	CcSEcCtD
Penbutolol—Diarrhoea—Methotrexate—hematologic cancer	0.000209	0.000263	CcSEcCtD
Penbutolol—Asthenia—Epirubicin—hematologic cancer	0.000205	0.000258	CcSEcCtD
Penbutolol—Dizziness—Methotrexate—hematologic cancer	0.000202	0.000254	CcSEcCtD
Penbutolol—Diarrhoea—Epirubicin—hematologic cancer	0.000195	0.000246	CcSEcCtD
Penbutolol—Headache—Methotrexate—hematologic cancer	0.000191	0.000241	CcSEcCtD
Penbutolol—Asthenia—Doxorubicin—hematologic cancer	0.000189	0.000239	CcSEcCtD
Penbutolol—Dizziness—Epirubicin—hematologic cancer	0.000189	0.000238	CcSEcCtD
Penbutolol—Nausea—Methotrexate—hematologic cancer	0.000181	0.000228	CcSEcCtD
Penbutolol—Diarrhoea—Doxorubicin—hematologic cancer	0.000181	0.000228	CcSEcCtD
Penbutolol—Headache—Epirubicin—hematologic cancer	0.000179	0.000225	CcSEcCtD
Penbutolol—Dizziness—Doxorubicin—hematologic cancer	0.000175	0.00022	CcSEcCtD
Penbutolol—Nausea—Epirubicin—hematologic cancer	0.00017	0.000214	CcSEcCtD
Penbutolol—Headache—Doxorubicin—hematologic cancer	0.000165	0.000208	CcSEcCtD
Penbutolol—Nausea—Doxorubicin—hematologic cancer	0.000157	0.000198	CcSEcCtD
Penbutolol—HTR1A—Signaling Pathways—HES1—hematologic cancer	2.67e-05	0.000207	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	2.66e-05	0.000206	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NCOR1—hematologic cancer	2.66e-05	0.000206	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	2.65e-05	0.000205	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	2.65e-05	0.000205	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOTCH1—hematologic cancer	2.65e-05	0.000205	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	2.65e-05	0.000205	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	2.65e-05	0.000205	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	2.64e-05	0.000205	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CSF2—hematologic cancer	2.63e-05	0.000203	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF1—hematologic cancer	2.63e-05	0.000203	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	2.62e-05	0.000202	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	2.6e-05	0.000201	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CD80—hematologic cancer	2.59e-05	0.000201	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	2.59e-05	0.000201	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	2.59e-05	0.000201	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CG—hematologic cancer	2.59e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KIT—hematologic cancer	2.59e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—NRAS—hematologic cancer	2.59e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FOXO1—hematologic cancer	2.59e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2—hematologic cancer	2.59e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDGFRB—hematologic cancer	2.58e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CB—hematologic cancer	2.56e-05	0.000198	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PTPN11—hematologic cancer	2.54e-05	0.000197	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDGFRA—hematologic cancer	2.54e-05	0.000197	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—JAK1—hematologic cancer	2.54e-05	0.000196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCG—hematologic cancer	2.54e-05	0.000196	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MAPK3—hematologic cancer	2.48e-05	0.000192	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	2.48e-05	0.000192	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CREB1—hematologic cancer	2.47e-05	0.000191	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	2.46e-05	0.00019	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	2.45e-05	0.000189	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—BRAF—hematologic cancer	2.43e-05	0.000188	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	2.42e-05	0.000187	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL2—hematologic cancer	2.41e-05	0.000187	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6R—hematologic cancer	2.4e-05	0.000186	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	2.4e-05	0.000186	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CREBBP—hematologic cancer	2.4e-05	0.000186	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	2.39e-05	0.000185	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	2.39e-05	0.000185	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2RA—hematologic cancer	2.37e-05	0.000183	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2—hematologic cancer	2.35e-05	0.000182	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TERT—hematologic cancer	2.34e-05	0.000181	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	2.34e-05	0.000181	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	2.34e-05	0.000181	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAP2K1—hematologic cancer	2.29e-05	0.000177	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	2.29e-05	0.000177	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	2.28e-05	0.000177	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CD—hematologic cancer	2.28e-05	0.000176	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3CA—hematologic cancer	2.26e-05	0.000174	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	2.25e-05	0.000174	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TSC2—hematologic cancer	2.23e-05	0.000173	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—KRAS—hematologic cancer	2.23e-05	0.000172	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	2.22e-05	0.000172	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	2.2e-05	0.00017	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	2.18e-05	0.000169	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FGF2—hematologic cancer	2.18e-05	0.000169	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	2.18e-05	0.000168	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	2.16e-05	0.000167	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3R1—hematologic cancer	2.15e-05	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	2.15e-05	0.000166	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	2.13e-05	0.000165	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	2.13e-05	0.000165	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	2.13e-05	0.000165	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	2.13e-05	0.000165	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	2.11e-05	0.000163	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	2.11e-05	0.000163	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—JAK2—hematologic cancer	2.09e-05	0.000162	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ESR1—hematologic cancer	2.09e-05	0.000161	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	2.08e-05	0.000161	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	2.08e-05	0.000161	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	2.07e-05	0.00016	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	2.06e-05	0.00016	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	2.06e-05	0.00016	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	2.06e-05	0.00016	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	2.06e-05	0.00016	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FN1—hematologic cancer	2.06e-05	0.00016	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CA—hematologic cancer	2.05e-05	0.000158	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MDM2—hematologic cancer	2.04e-05	0.000158	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—BAD—hematologic cancer	2.04e-05	0.000158	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	2.04e-05	0.000158	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	2.03e-05	0.000157	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	2.02e-05	0.000156	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	2.02e-05	0.000156	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	2.02e-05	0.000156	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	2.02e-05	0.000156	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	2.02e-05	0.000156	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CB—hematologic cancer	1.98e-05	0.000154	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MTOR—hematologic cancer	1.98e-05	0.000154	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	1.98e-05	0.000153	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CD80—hematologic cancer	1.98e-05	0.000153	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	1.98e-05	0.000153	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	1.97e-05	0.000153	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KIT—hematologic cancer	1.97e-05	0.000153	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	1.97e-05	0.000153	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	1.96e-05	0.000152	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	1.94e-05	0.00015	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	1.94e-05	0.00015	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	1.93e-05	0.00015	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	1.92e-05	0.000149	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	1.92e-05	0.000149	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	1.92e-05	0.000148	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	1.91e-05	0.000148	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	1.9e-05	0.000147	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HRAS—hematologic cancer	1.89e-05	0.000147	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	1.89e-05	0.000146	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	1.88e-05	0.000145	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CREB1—hematologic cancer	1.88e-05	0.000145	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	1.87e-05	0.000145	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	1.87e-05	0.000145	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1B—hematologic cancer	1.86e-05	0.000144	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—BRAF—hematologic cancer	1.85e-05	0.000143	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—hematologic cancer	1.84e-05	0.000143	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL2—hematologic cancer	1.84e-05	0.000142	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6R—hematologic cancer	1.83e-05	0.000142	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	1.83e-05	0.000142	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CASP3—hematologic cancer	1.83e-05	0.000141	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	1.83e-05	0.000141	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2—hematologic cancer	1.82e-05	0.000141	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—hematologic cancer	1.81e-05	0.00014	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	1.81e-05	0.00014	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.8e-05	0.000139	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	1.79e-05	0.000138	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCND1—hematologic cancer	1.78e-05	0.000137	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	1.78e-05	0.000137	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	1.77e-05	0.000137	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—JUN—hematologic cancer	1.77e-05	0.000137	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.76e-05	0.000136	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	1.75e-05	0.000135	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	1.74e-05	0.000134	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	1.74e-05	0.000134	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	1.73e-05	0.000134	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1A—hematologic cancer	1.72e-05	0.000133	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.72e-05	0.000133	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PTEN—hematologic cancer	1.71e-05	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	1.71e-05	0.000132	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	1.7e-05	0.000131	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	1.7e-05	0.000131	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK8—hematologic cancer	1.68e-05	0.00013	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	1.67e-05	0.00013	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—hematologic cancer	1.67e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	1.66e-05	0.000129	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF2—hematologic cancer	1.66e-05	0.000128	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	1.64e-05	0.000127	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EP300—hematologic cancer	1.64e-05	0.000127	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	1.63e-05	0.000126	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	1.63e-05	0.000126	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	1.62e-05	0.000126	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	1.6e-05	0.000123	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—JAK2—hematologic cancer	1.59e-05	0.000123	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SRC—hematologic cancer	1.59e-05	0.000123	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	1.59e-05	0.000123	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	1.58e-05	0.000122	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	1.58e-05	0.000122	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	1.56e-05	0.000121	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MDM2—hematologic cancer	1.55e-05	0.00012	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—hematologic cancer	1.55e-05	0.00012	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	1.55e-05	0.00012	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	1.55e-05	0.00012	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—hematologic cancer	1.53e-05	0.000119	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NRAS—hematologic cancer	1.53e-05	0.000118	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MTOR—hematologic cancer	1.51e-05	0.000117	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	1.51e-05	0.000117	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	1.51e-05	0.000117	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	1.48e-05	0.000115	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	1.48e-05	0.000114	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	1.47e-05	0.000114	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK3—hematologic cancer	1.47e-05	0.000113	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	1.45e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	1.45e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	1.45e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	1.44e-05	0.000112	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	1.44e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	1.44e-05	0.000111	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MYC—hematologic cancer	1.43e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	1.42e-05	0.00011	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—hematologic cancer	1.42e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	1.42e-05	0.00011	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	1.42e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	1.41e-05	0.000109	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	1.41e-05	0.000109	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	1.41e-05	0.000109	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	1.4e-05	0.000109	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CASP3—hematologic cancer	1.39e-05	0.000108	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2—hematologic cancer	1.39e-05	0.000107	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	1.38e-05	0.000107	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—hematologic cancer	1.38e-05	0.000107	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	1.38e-05	0.000107	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	1.37e-05	0.000106	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	1.37e-05	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCND1—hematologic cancer	1.35e-05	0.000105	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—JUN—hematologic cancer	1.35e-05	0.000104	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	1.34e-05	0.000104	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	1.34e-05	0.000103	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	1.34e-05	0.000103	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	1.33e-05	0.000103	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KRAS—hematologic cancer	1.32e-05	0.000102	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	1.31e-05	0.000101	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	1.31e-05	0.000101	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTEN—hematologic cancer	1.31e-05	0.000101	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	1.3e-05	0.000101	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	1.3e-05	0.000101	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	1.28e-05	9.89e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	1.27e-05	9.86e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	1.27e-05	9.86e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	1.27e-05	9.8e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EP300—hematologic cancer	1.25e-05	9.64e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	1.24e-05	9.59e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	1.23e-05	9.54e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	1.22e-05	9.45e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	1.22e-05	9.43e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SRC—hematologic cancer	1.21e-05	9.37e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CA—hematologic cancer	1.21e-05	9.36e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	1.21e-05	9.34e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	1.19e-05	9.24e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	1.19e-05	9.22e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	1.18e-05	9.13e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TP53—hematologic cancer	1.17e-05	9.05e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—hematologic cancer	1.17e-05	9.04e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.17e-05	9.03e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NRAS—hematologic cancer	1.17e-05	9.02e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	1.14e-05	8.83e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.13e-05	8.78e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.13e-05	8.76e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HRAS—hematologic cancer	1.12e-05	8.66e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	1.12e-05	8.64e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	1.11e-05	8.59e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	1.11e-05	8.57e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.09e-05	8.4e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.08e-05	8.38e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—hematologic cancer	1.07e-05	8.29e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	1.05e-05	8.11e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	1.03e-05	7.94e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1e-05	7.76e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—hematologic cancer	9.88e-06	7.65e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	9.63e-06	7.45e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	9.42e-06	7.29e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	9.32e-06	7.21e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	9.22e-06	7.13e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	9.12e-06	7.05e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TP53—hematologic cancer	8.92e-06	6.9e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	8.91e-06	6.9e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	8.72e-06	6.75e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	8.53e-06	6.6e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HRAS—hematologic cancer	8.53e-06	6.6e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	8.35e-06	6.46e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—hematologic cancer	8.16e-06	6.31e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	7.87e-06	6.09e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	7.7e-06	5.96e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—hematologic cancer	7.53e-06	5.82e-05	CbGpPWpGaD
